Your browser doesn't support javascript.
loading
YY1 Haploinsufficiency Causes an Intellectual Disability Syndrome Featuring Transcriptional and Chromatin Dysfunction.
Gabriele, Michele; Vulto-van Silfhout, Anneke T; Germain, Pierre-Luc; Vitriolo, Alessandro; Kumar, Raman; Douglas, Evelyn; Haan, Eric; Kosaki, Kenjiro; Takenouchi, Toshiki; Rauch, Anita; Steindl, Katharina; Frengen, Eirik; Misceo, Doriana; Pedurupillay, Christeen Ramane J; Stromme, Petter; Rosenfeld, Jill A; Shao, Yunru; Craigen, William J; Schaaf, Christian P; Rodriguez-Buritica, David; Farach, Laura; Friedman, Jennifer; Thulin, Perla; McLean, Scott D; Nugent, Kimberly M; Morton, Jenny; Nicholl, Jillian; Andrieux, Joris; Stray-Pedersen, Asbjørg; Chambon, Pascal; Patrier, Sophie; Lynch, Sally A; Kjaergaard, Susanne; Tørring, Pernille M; Brasch-Andersen, Charlotte; Ronan, Anne; van Haeringen, Arie; Anderson, Peter J; Powis, Zöe; Brunner, Han G; Pfundt, Rolph; Schuurs-Hoeijmakers, Janneke H M; van Bon, Bregje W M; Lelieveld, Stefan; Gilissen, Christian; Nillesen, Willy M; Vissers, Lisenka E L M; Gecz, Jozef; Koolen, David A; Testa, Giuseppe.
Afiliação
  • Gabriele M; Laboratory of Stem Cell Epigenetics, Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy.
  • Vulto-van Silfhout AT; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
  • Germain PL; Laboratory of Stem Cell Epigenetics, Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy.
  • Vitriolo A; Laboratory of Stem Cell Epigenetics, Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy.
  • Kumar R; School of Medicine and Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
  • Douglas E; SA Clinical Genetics Service, SA Pathology, Adelaide, SA 5000, Australia; School of Medicine, University of Adelaide, Adelaide, SA 5000, Australia.
  • Haan E; SA Clinical Genetics Service, SA Pathology, Adelaide, SA 5000, Australia; School of Medicine, University of Adelaide, Adelaide, SA 5000, Australia.
  • Kosaki K; Center for Medical Genetics, Keio University School of Medicine, 160-8582 Tokyo, Japan.
  • Takenouchi T; Center for Medical Genetics, Keio University School of Medicine, 160-8582 Tokyo, Japan.
  • Rauch A; Institute of Medical Genetics, University of Zurich, 8952 Schlieren-Zurich, Switzerland.
  • Steindl K; Institute of Medical Genetics, University of Zurich, 8952 Schlieren-Zurich, Switzerland.
  • Frengen E; Department of Medical Genetics, University of Oslo and Oslo University Hospital, 0315 Oslo, Norway.
  • Misceo D; Department of Medical Genetics, University of Oslo and Oslo University Hospital, 0315 Oslo, Norway.
  • Pedurupillay CRJ; Department of Medical Genetics, University of Oslo and Oslo University Hospital, 0315 Oslo, Norway.
  • Stromme P; Division of Paediatric and Adolescent Medicine, Oslo University Hospital and University of Oslo, 0313 Oslo, Norway.
  • Rosenfeld JA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Shao Y; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Craigen WJ; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Schaaf CP; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Rodriguez-Buritica D; Division of Genetics, Department of Pediatrics, University of Texas Health, Houston, TX 77030, USA.
  • Farach L; Division of Genetics, Department of Pediatrics, University of Texas Health, Houston, TX 77030, USA.
  • Friedman J; Departments of Neurosciences and Pediatrics, University of California, San Diego, and Rady Children's Hospital, San Diego, CA 92123, USA.
  • Thulin P; Department of Neurology, University of Utah, San Diego, CA 92123, USA.
  • McLean SD; Clinical Genetics Section, Children's Hospital of San Antonio, San Antonio, TX 78207, USA.
  • Nugent KM; Clinical Genetics Section, Children's Hospital of San Antonio, San Antonio, TX 78207, USA.
  • Morton J; Birmingham Women's Hospital, B15 2TG Birmingham, UK.
  • Nicholl J; SA Clinical Genetics Service, SA Pathology, Adelaide, SA 5000, Australia; School of Medicine, University of Adelaide, Adelaide, SA 5000, Australia.
  • Andrieux J; Institut de Génétique Médicale, Hopital Jeanne de Flandre, 59000 Lille, France.
  • Stray-Pedersen A; Human and Medical Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Chambon P; Laboratory of Cytogenetics, Rouen University Hospital, 76031 Rouen, France.
  • Patrier S; Service d'Anatomie Pathologique, Rouen University Hospital, 76031 Rouen, France.
  • Lynch SA; National Centre for Medical Genetics, Our Lady's Children's Hospital, D12 V004 Dublin, Ireland.
  • Kjaergaard S; Department of Clinical Genetics, Rigshospitalet, 2100 Copenhagen, Denmark.
  • Tørring PM; Department of Clinical Genetics, Odense University Hospital, 5000 Odense, Denmark.
  • Brasch-Andersen C; Department of Clinical Genetics, Odense University Hospital, 5000 Odense, Denmark.
  • Ronan A; Hunter Genetics, Waratah, NSW 2298, Australia.
  • van Haeringen A; Department of Clinical Genetics, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.
  • Anderson PJ; Australian Craniofacial Unit, Women's and Children's Hospital, North Adelaide, SA 5006, Australia.
  • Powis Z; Ambry Genetics, Aliso Viejo, CA 92656, USA.
  • Brunner HG; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
  • Pfundt R; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
  • Schuurs-Hoeijmakers JHM; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
  • van Bon BWM; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
  • Lelieveld S; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
  • Gilissen C; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
  • Nillesen WM; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
  • Vissers LELM; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
  • Gecz J; School of Medicine and Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia; South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.
  • Koolen DA; Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
  • Testa G; Laboratory of Stem Cell Epigenetics, Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy. Electronic address: giuseppe.testa@unimi.it.
Am J Hum Genet ; 100(6): 907-925, 2017 Jun 01.
Article em En | MEDLINE | ID: mdl-28575647
ABSTRACT
Yin and yang 1 (YY1) is a well-known zinc-finger transcription factor with crucial roles in normal development and malignancy. YY1 acts both as a repressor and as an activator of gene expression. We have identified 23 individuals with de novo mutations or deletions of YY1 and phenotypic features that define a syndrome of cognitive impairment, behavioral alterations, intrauterine growth restriction, feeding problems, and various congenital malformations. Our combined clinical and molecular data define "YY1 syndrome" as a haploinsufficiency syndrome. Through immunoprecipitation of YY1-bound chromatin from affected individuals' cells with antibodies recognizing both ends of the protein, we show that YY1 deletions and missense mutations lead to a global loss of YY1 binding with a preferential retention at high-occupancy sites. Finally, we uncover a widespread loss of H3K27 acetylation in particular on the YY1-bound enhancers, underscoring a crucial role for YY1 in enhancer regulation. Collectively, these results define a clinical syndrome caused by haploinsufficiency of YY1 through dysregulation of key transcriptional regulators.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transcrição Gênica / Cromatina / Fator de Transcrição YY1 / Haploinsuficiência / Deficiência Intelectual Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transcrição Gênica / Cromatina / Fator de Transcrição YY1 / Haploinsuficiência / Deficiência Intelectual Idioma: En Ano de publicação: 2017 Tipo de documento: Article